Effects of Tenoten on Anxiety and Depression Disorders in Patients with Epilepsy-Reference-Cited by-同舟云学术

Effects of Tenoten on Anxiety and Depression Disorders in Patients with Epilepsy

Published:2012-09 Issue:5 Volume:153 Page:704-706
ISSN:0007-4888
Container-title:Bulletin of Experimental Biology and Medicine
language:en
Short-container-title:Bull Exp Biol Med

Author:

Delger A. B.,Avakyan G. N.,Oleinikova O. M.,Bogomazova M. A.,Chromych E. A.,Lagutin Iu. V.

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10517-012-1804-7.pdf

Reference8 articles.

1. G. N. Avakyan, Atmosfera, No. 4, 4-8 (2005).

2. O. I. Epstein, M. B. Stark, A. M. Dygai, et al., Pharmacology of Ultralow Dose Antibodies to Endogenous Function Regulators [in Russian], Moscow (2005).

3. B. Baran, M. Farkas, and P. Rajna, Ideggyogy Sz., 55, No. 9-10, 303-310 (2002).

4. M. J. Jackson and D. Turkington, J. Neurol. Neurosurg. Psychiatry, 76, Suppl. 1, i45-i47 (2005).

5. T. Kapitany, G. Glauninger, and B. Schimka, Psychiatrische Aspekte, Wien (2001).

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological treatment of anxiety disorders in adults with epilepsy;Expert Opinion on Pharmacotherapy;2018-10

2. MicroRNA‑155 contributes to the occurrence of epilepsy through the PI3K/Akt/mTOR signaling pathway;International Journal of Molecular Medicine;2018-06-01

3. Dose–Response Effect of Antibodies to S100 Protein and Cannabinoid Receptor Type 1 in Released-Active Form in the Light–Dark Test in Mice;Dose-Response;2018-04-01